"With Salesforce's ( NYSE: CRM) Q4 FY2026 earnings due February 25, three major Wall Street firms slashed their price targets on the stock Monday morning, raising a pointed question for investors: is it a stock that's dangerous to overlook, or simply dangerous to own? Salesforce stock has shed 30.1% year-to-date, sitting at $185.16 as of Friday's close. The cuts this morning were steep: Barclays: To $265 from $338 (still Overweight) Evercore ISI: To $260 from $340 (still Outperform) Jefferies: To $250 from $375 (still Buy)"
"The underlying numbers tell a complicated story. Q3 revenue grew 9% year-over-year to $10.26 billion, modest for a mega-cap tech company. But net income surged 36.61% to $2.09 billion, and Agentforce ARR hit nearly $1.4 billion, up 114% year-over-year. The company also returned $4.2 billion to shareholders in Q3 alone. The tension is real. Top-line growth is incremental, AI competition risks are genuine, and Reddit sentiment has turned bearish with a score of 28 out of 100."
Salesforce's stock has fallen about 30.1% year-to-date, and several major Wall Street firms sharply lowered price targets while keeping bullish ratings. Q3 revenue rose 9% year-over-year to $10.26 billion, net income increased 36.61% to $2.09 billion, and Agentforce ARR reached nearly $1.4 billion, up 114% year-over-year. The company returned $4.2 billion to shareholders in Q3. Analysts cite genuine AI competition risks and incremental top-line growth, while Reddit sentiment shows bearishness with a 28/100 score. Analysts who cut targets still project 35%–50% upside, and the upcoming Q4 earnings report will test Agentforce momentum.
Read at 24/7 Wall St.
Unable to calculate read time
Collection
[
|
...
]